Back
Mirum Pharmaceuticals Quote, Financials, Valuation and Earnings
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Buy
69
MIRM
Mirum Pharmaceuticals
Last Price:
41.17
Seasonality Move:
33.22%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeMirum Pharmaceuticals Price Quote
$41.17
+0.45 (+1.11%)
(Updated: November 6, 2024 at 3:45 PM ET)
Mirum Pharmaceuticals Key Stats
Buy
69
Mirum Pharmaceuticals (MIRM)
is a Buy
Day range:
$38.16 - $41.00
52-week range:
$23.14 - $45.23
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.00
P/B ratio:
8.48%
Volume:
271.7K
Avg. volume:
298.9K
1-year change:
35.73%
Market cap:
$1.9B
Revenue:
$186.4M
EPS:
$-2.34
How Much Does Mirum Pharmaceuticals Make?
-
How Much Are Mirum Pharmaceuticals's Sales Annually?
MIRM Revenues are $186.4M -
How Much Profit Does Mirum Pharmaceuticals's Make A Year?
MIRM net income is -$163.4M
Is Mirum Pharmaceuticals Growing As A Company?
-
What Is Mirum Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.08% -
What Is Mirum Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Mirum Pharmaceuticals Stock Price Performance
-
Did Mirum Pharmaceuticals Stock Go Up Last Month?
Mirum Pharmaceuticals share price went up by 3.72% last month -
Did MIRM's Share Price Rise Over The Last Year?
MIRM share price rose by 35.73% over the past 1 year
What Is Mirum Pharmaceuticals 52-Week High & Low?
-
What Is Mirum Pharmaceuticals’s 52-Week High Share Price?
Mirum Pharmaceuticals has traded as high as $45.23 over the past 52 weeks -
What Is Mirum Pharmaceuticals’s 52-Week Low Share Price?
Mirum Pharmaceuticals has traded as low as $23.14 over the past 52 weeks
Mirum Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Mirum Pharmaceuticals?
-
How Much Debt Does Mirum Pharmaceuticals Have?
Total long term debt quarterly is $307.2M -
How Much Cash Does Mirum Pharmaceuticals Have?
Cash and short term investments quarterly total is $278.4M -
What Is Mirum Pharmaceuticals’s Book Value Per Share?
Book value per share is 4.81
Is Mirum Pharmaceuticals Cash Flow Positive?
-
What Is MIRM Cash Flow From Operations?
Cash flow from operations (TTM) is -$23.4M -
What Is Mirum Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $217.4M -
What Is Mirum Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$257.5M
Mirum Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
MIRM return on invested capital is -21.06% -
What Is Mirum Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -17.88% -
What Is MIRM Return On Equity?
ROE is a measure of profitability and is -51.5%
Mirum Pharmaceuticals Earnings Date & Stock Price
-
What Is Mirum Pharmaceuticals's Stock Price Today?
A single share of MIRM can be purchased today for 40.72 -
What Is Mirum Pharmaceuticals’s Stock Symbol?
Mirum Pharmaceuticals trades on the nasdaq under the ticker symbol: MIRM -
When Is Mirum Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Mirum Pharmaceuticals is scheduled on November 8, 2024 -
When Is MIRM's next ex-dividend date?
Mirum Pharmaceuticals's next ex-dividend date is November 6, 2024 -
How To Buy Mirum Pharmaceuticals Stock?
You can buy Mirum Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Mirum Pharmaceuticals Competitors
-
Who Are Mirum Pharmaceuticals's Competitors?
Below is a list of companies who compete with Mirum Pharmaceuticals or are related in some way:
Mirum Pharmaceuticals Dividend Yield
-
What Is MIRM Dividend Yield?
Mirum Pharmaceuticals’s dividend yield currently is 0% -
What Is Mirum Pharmaceuticals’s Payout Ratio?
Mirum Pharmaceuticals’s payout ratio is 0% -
When Did Mirum Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 6, 2024 -
What Is Mirum Pharmaceuticals’s Dividend Per Share?
Mirum Pharmaceuticals pays a dividend of $0.00 per share
Mirum Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -12.25% |
| Revenue: | 107.68% | 3.72% |
Analyst Recommendations
| Buy Recommendations: | 7 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 59.45 |
| Upside from Last Price: | 46.01% |